Corbus Pharmaceuticals Holdings logo
Corbus Pharmaceuticals Holdings CRBP
$ 10.41 -5.36%

Квартальный отчет 2024-Q3
добавлен 07.11.2024

report update icon

Corbus Pharmaceuticals Holdings Мультипликаторы 2011-2024 | CRBP

Мультипликаторы по годам Corbus Pharmaceuticals Holdings

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.0 -0.3 -0.1 -1.3 -5.8 -7.4 -12.6 -13.5 -5.0 -16.7 - - -

P/S

- - 2.9 38.1 11.5 85.3 167.6 141.0 68.2 - - - -

EPS

-10.3 -10.2 -11.2 -1.4 -1.1 -1.0 -0.7 -0.5 -0.3 -0.1 -0.1 - -

EV (Enterprise Value)

66.5 млн 27.7 млн 16.1 млн 121 млн 426 млн 389 млн 356 млн 263 млн 35.8 млн 36.8 млн 1.79 млн - -

EBITDA per Share

-10.3 -9.37 -13.4 -1.48 -1.19 -0.987 -0.644 -0.484 -0.281 -0.131 - - -

EV/EBITDA

-0.2 -0.7 -5.1 -6.6 -10.7 -12.8 -3.6 -13.7 - - -

PEG

-0.01 -0.0 -0.0 0.05 0.41 0.15 0.39 0.18 0.04 0.04 - - -

P/B

-6.5 0.3 0.0 3.3 67.3 15.0 7.1 30.2 4.9 7.2 - - -

P/CF

-1.2 -0.3 -0.1 -1.5 -8.6 -12.7 -14.3 -19.4 -9.3 -17.5 - - -

ROE %

645.98 -128.36 -66.04 -245.76 -1160.42 -202.27 -56.11 -224.22 -98.51 -43.33 - - -

ROA %

-157.76 -63.86 -42.37 -108.77 -145.40 -118.48 -48.41 -111.80 -68.74 -38.49 - - -

ROCE %

652.85 -120.75 -81.02 -174.45 -540.90 -196.36 -55.40 -222.31 -95.76 -45.15 - - -

Current Ratio

0.8 2.0 2.8 2.9 1.1 2.4 8.0 2.0 3.5 8.9 - - -

DSO

- - - 239.0 27.1 - - 254.1 - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Corbus Pharmaceuticals Holdings

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.15 -0.9 -0.83 - -2.27 -2.05 -4.24 - -2.11 -3.18 -2.26 - -0.02 -0.15 -0.14 - -0.43 -0.52 -0.43 - -0.32 0.03 -0.43 - -0.26 -0.21 -0.21 -0.2 -0.14 -0.15 -0.16 -0.17 -0.12 -0.11 -0.08 - -0.06 -0.1 -0.06 - -0.03 -0.02 -0.02 - -0.01 - - - - - - - - - -

EBITDA per Share

-1.27 -0.98 -1.14 - -2.1 -1.87 -4.09 - -1.92 -2.91 -2 - -0.1 -0.14 -0.13 - -0.41 -0.51 -0.43 - -0.39 0.03 -0.43 - -0.26 -0.21 -0.21 -0.2 -0.14 -0.14 -0.16 -0.17 -0.12 -0.11 -0.08 - -0.06 -0.1 -0.06 - -0.03 -0.02 -0.02 - -0.01 - - - - - - - - - -

ROE %

-3246.35 -6459.31 -6543.60 -3422.19 -3443.12 -241.94 -176.47 -63.15 -65.95 -47.82 -43.31 -42.63 -119.70 -193.97 -255.87 -226.74 -564.39 -824.96 -705.84 -728.75 -781.79 -497.20 -576.01 -139.39 -157.90 -116.90 -85.68 -56.11 -122.48 -170.37 -204.71 -224.22 -164.43 -129.57 -111.12 -70.70 -81.95 -68.11 -48.20 -21.84 -18.50 -3.91 4.70 3.34 3.34 - - - - - - - - - -

ROA %

-48.17 -67.48 -80.99 -82.16 -94.05 -78.24 -74.29 -37.90 -39.72 -29.65 -27.71 -27.49 -61.61 -93.90 -116.94 -100.35 -142.66 -150.86 -109.23 -91.31 -122.39 -111.15 -141.22 -81.65 -97.61 -76.94 -62.15 -48.41 -74.76 -94.25 -106.78 -111.80 -86.98 -74.60 -71.08 -49.34 -59.33 -51.82 -39.56 -19.39 -38.89 -48.39 -40.74 -19.49 -19.49 - - - - - - - - - -

ROCE %

-3070.00 -6100.73 -6177.99 -3232.13 -3251.63 -230.11 -169.05 -58.38 -76.25 -74.62 -71.38 -56.42 -131.46 -188.62 -251.16 -225.29 -632.86 -965.40 -853.47 -810.62 -864.74 -511.30 -584.02 -142.26 -161.06 -118.97 -86.56 -56.35 -122.46 -170.22 -204.59 -224.07 -164.26 -129.56 -111.09 -70.71 -84.66 -73.52 -52.92 -23.68 -21.13 -4.64 3.28 2.54 2.54 - - - - - - - - - -

Current Ratio

12.0 5.8 4.4 0.8 1.0 1.3 1.5 2.0 2.3 2.5 2.8 2.8 2.9 2.8 2.9 1.8 1.8 1.8 1.8 1.1 1.1 1.1 1.1 2.4 2.4 2.4 2.4 7.3 7.3 7.3 7.3 2.0 2.0 2.0 2.0 3.3 3.3 3.3 3.3 8.9 8.9 11.1 8.9 0.3 0.3 - - - - - - - - - -

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD